[Adverse obstetric and perinatal outcome with in vitro fertilization technology: A French nationwide population-based study].

Risques de morbidité maternelle et périnatale en fécondation in vitro : une étude nationale de cohorte française.

Journal

Gynecologie, obstetrique, fertilite & senologie
ISSN: 2468-7189
Titre abrégé: Gynecol Obstet Fertil Senol
Pays: France
ID NLM: 101693805

Informations de publication

Date de publication:
04 2020
Historique:
received: 14 10 2019
pubmed: 15 2 2020
medline: 6 5 2021
entrez: 15 2 2020
Statut: ppublish

Résumé

The objective of this study was to quantify the risk of maternal and perinatal morbidity with in vitro fertilization (IVF) technology compared to non-IVF pregnancies in a recent French national cohort. The data was extracted from the hospital information data system, including all pregnancies with a delivery from 2013 to 2016. The risks of preterm birth, maternal morbidity (venous and arterial thrombosis, gestational diabetes, vascular disorders, placenta previa, placenta abruption), hypotrophy and congenital malformation were compared in both groups in univariate and multivariate analysis after adjustment on the characteristics of women (age, parity, obesity, tobacco dependence, history of diabetes or high blood pressure), multiple deliveries and sex of children. In all, 2,875,662 pregnancies and 2,922,712 births were analyzed, of which 49,224 were derived from IVF (1.7%). In multivariate analysis, all risks were significantly higher in IVF: premature deliveries (OR The results of this study on a large cohort of recent births in France confirm that there was an increased risk of maternal and perinatal morbidities in IVF. These risks were similar to those published in the international literature. This study is the starting point for a forthcoming surveillance.

Identifiants

pubmed: 32058045
pii: S2468-7189(20)30051-9
doi: 10.1016/j.gofs.2020.02.002
pii:
doi:

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

351-358

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

F Pessione (F)

Direction PEGh, agence de la biomédecine, 1, avenue du Stade-de-France, 93212 La Plaine Saint-Denis, France. Electronic address: Fabienne.pessione@biomedecine.fr.

J De Mouzon (J)

Unilabs, direction médicale, Clichy-La-Garenne, France.

A Deveaux (A)

Centre d'assistance médicale à la procréation, biologie de la reproduction, CHU d'Amiens, Amiens, France.

S Epelboin (S)

Centre d'assistance médicale à la procréation, gynécologie obstétrique, médecine de la reproduction, université Paris 7 Diderot, groupe hospitalier Bichat Claude-Bernard, AP-HP, Paris, France.

M-J Gervoise-Boyer (MJ)

Service de médecine et biologie de la reproduction, hôpital Saint-Joseph, Marseille 8, France.

C Jimenez (C)

Centre d'assistance médicale à la procréation, biologie de la reproduction, CHU de Bordeaux, Bordeaux, France.

R Levy (R)

Inserm, équipe lipodystrophies génétiques et acquises, service de biologie de la reproduction-CECOS, Saint-Antoine Research center, Sorbonne université, hôpital Tenon, AP-HP, 75020 Paris, France.

M Valentin (M)

Diagnostic anténatal, gynécologie obstétrique, université Paris 7 Diderot, groupe hospitalier Bichat Claude-Bernard, AP-HP, Paris, France.

G Viot (G)

Unité de génétique clinique de La Muette, 50, rue Nicolo, 75116 Paris, France.

M Bergère (M)

Direction PEGh, agence de la biomédecine, 1, avenue du Stade-de-France, 93212 La Plaine Saint-Denis, France.

F Merlet (F)

Direction PEGh, agence de la biomédecine, 1, avenue du Stade-de-France, 93212 La Plaine Saint-Denis, France.

P Jonveaux (P)

Direction PEGh, agence de la biomédecine, 1, avenue du Stade-de-France, 93212 La Plaine Saint-Denis, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH